Global Corporate Affairs Archives | Page 150 of 1087 | Be Korea-savvy

Archive by category Global Corporate Affairs

Entertainment Without Borders: AI-Media and Lightning International Join Forces to Make FAST Channels Accessible to Everyone

Entertainment Without Borders: AI-Media and Lightning International Join Forces to Make FAST Channels Accessible to Everyone

SYDNEY and HONG KONG, May 22, 2025 (Korea Bizwire) – AI-Media Technologies Limited (“AI-Media”), a global leader in live captioning and translation solutions, has entered a groundbreaking partnership with Lightning International (“Lightning”), the leading distributor of Free Ad-Supported Television (FAST) channels. This collaboration aims to break down barriers and bring the joy of entertainment to every corner of the [...]

For the First Time in Dubai Two Restaurants are Awarded Three MICHELIN Stars

For the First Time in Dubai Two Restaurants are Awarded Three MICHELIN Stars

Trèsind Studio becomes the first Indian restaurant in the world to receive Three MICHELIN Stars FZN by Björn Frantzén enters the Guide with Three MICHELIN Stars in its first year The MICHELIN Guide Dubai 2025 selection also includes 2 new One MICHELIN Stars and 5 new Bib Gourmand restaurants DUBAI, United Arab Emirates, May 23, [...]

Sniff Hotels is now 123 Reserve: New name, same mission to simplify global hotel bookings

Sniff Hotels is now 123 Reserve: New name, same mission to simplify global hotel bookings

ASCURRA, SANTA CATARINA, Brazil, May 22, 2025 (Korea Bizwire) – The international hotel booking platform Sniff Hotels officially announces its brand and domain migration to 123 Reserve. This change is part of a global growth strategy and market repositioning, while maintaining its commitment to a fast, secure, and intuitive booking experience for travelers around the world. “The transition [...]

Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025

Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025

BI 765063 in combination with programmed cell death-1 (PD1) inhibitor antibody ezabenlimab + cetuximab demonstrated a well-tolerated safety profile and potentially promising efficacy signals as second-line treatment in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).  Next generation SIRPα inhibitor BI 770371 was shown to be well tolerated alone and in combination with PD1 [...]

Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences

Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences

Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii), which was developed using Azymetric™, to be presented at ASCO and highlight its potential to transform the treatment landscape for first-line HER2-positive gastroesophageal cancer ZW171 Trial-in-Progress (TiP) poster at ASCO, ZW191 TiP poster [...]

VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility

VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility

Amended Terms with Alumni Capital Reinforce Disciplined Capital Deployment and Long-Term Growth Priorities KUALA LUMPUR, Malaysia, May 22, 2025 (Korea Bizwire) – VCI Global Limited (NASDAQ: VCIG) (“VCI Global”), a diversified global holding company with a strategic focus on AI & Robotics, Fintech, Cybersecurity, Renewable Energy, and Capital Market Consultancy, today announced a significant amendment [...]

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

TEL AVIV, Israel, May 22, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it is increasing the maximum tender amount of its tender offer previously announced on May 19, 2025 from $2.0 billion (equivalent) aggregate cash purchase price (exclusive of accrued and unpaid interest) to approximately $2.25 [...]

Hivello’s Data Proves DePINs Growing Momentum

Hivello’s Data Proves DePINs Growing Momentum

LONDON and AMSTERDAM, May 22, 2025 (Korea Bizwire) – Is the DePIN revolution going to lead to a DePIN Summer? The recent $1.6B blackout across Europe, highlights the necessity for Decentralisation and Hivello’s growth data suggests the need is fast getting met. The recent $1.6 billion blackout across parts of Europe, highlighted by Forbes in May 2025, [...]

Philippine Stock Exchange Adopts Nasdaq Eqlipse Trading to Enhance Market Infrastructure

Philippine Stock Exchange Adopts Nasdaq Eqlipse Trading to Enhance Market Infrastructure

Upgrade to Nasdaq Eqlipse Trading will enhance liquidity and resilience of Philippine marketplace Expands Nasdaq’s deep technology footprint across the country’s financial services industry MANILA and NEW YORK, May 22, 2025 (Korea Bizwire) — Nasdaq (Nasdaq: NDAQ) and The Philippine Stock Exchange, Inc. (PSE) today announced a significant expansion of their technology partnership, which will [...]

LambdaTest Launches SmartUI MCP Server to Bring Human-Like Intelligence to Visual Testing

LambdaTest Launches SmartUI MCP Server to Bring Human-Like Intelligence to Visual Testing

New AI-native tool simulates human perception to detect and fix UI issues the way real users experience them San Francisco, CA, May 22, 2025 (Korea Bizwire) – LambdaTest, a unified agentic AI and cloud engineering platform, has introduced the SmartUI MCP Server, a revolutionary approach to visual regression testing that blends AI-native automation with human-like intelligence. [...]